CA
NZ
UK
AU
IND
US
The most important fact about Anebulo Pharmaceuticals, Inc. (OTC:ANEB) is not any single day's price change but where the stock now lives. In early 2026 the clinical-stage biotech chose to leave theNasdaqand step back from full SEC reporting, a decision that fundamentally changes how …
When a stock already trades for a fraction of a cent, a steep percentage drop can look alarming while signifying very little in absolute terms. That is the situation facing Aoxing Pharmaceutical Company, Inc (OTC:AOXG), a China-focused specialty-pharmaceutical name whose shares now change hands …
Few micro-cap healthcare names have reinvented themselves as abruptly as Apimeds Pharmaceuticals US, Inc (NYSE American:APUS). A specialty pharmaceutical company that only completed its initial public offering in May 2025, Apimeds has since bolted a cryptocurrency-treasury strategy onto its business, merging with MindWave Innovations …
Acutus Medical Inc (OTC:AFIB) is a cautionary tale of a once-Nasdaq-listed medical-device maker that has effectively wound down its commercial ambitions. Formerly a developer of catheter-based tools for treating cardiac arrhythmias, the company has retreated to a narrow manufacturing-and-distribution role and now trades on …
A single-day surge of the kind flagged for Aibotics Inc (OTC:AIBT) is exactly the sort of move that turns speculative eyes toward a sub-penny stock, and exactly the sort that deserves scrutiny before any excitement. Aibotics trades for a tiny fraction of a cent …
Firefly Neuroscience has spent 2026 building a case that artificial intelligence can sharpen how clinicians read the brain, yet its shares remain caught in theVolatilitycommon to micro-capMedTechnames. On September 9, 2026, the stock closed near $1.06, giving the Nasdaq-listed company a market value of …
Few small-cap biotechs have tested investor patience quite like ADC Therapeutics (NYSE: ADCT). The commercial-stage cancer-drug maker, best known for its approved lymphoma therapy ZYNLONTA, has seen its shares slide to around $1.22, leaving a marketCapitalizationnear $156 million. The latest roughly 6% retreat keeps …
Adagio Medical Holdings (NASDAQ:ADGM) sits at an unusual crossroads: a medical-device company advancing a differentiated cardiac-ablation platform through late-stage regulatory milestones, yet trading as a deeply depressed micro-cap near 60 cents. That tension, clinical and regulatory momentum on one side and a fragileMarket Valueand …
ADMABiologicshas been one of the more talked-about names in the plasma-derived biologics space this year, but the conversation in September 2026 is less about growth and more about scrutiny. After a multi-year run that turned the Ramsey, New Jersey company into a profitable specialty-immunoglobulin …
A sharp percentage pop in a sub-penny stock always draws eyes, and ADM Tronics Unlimited (OTC:ADMT) is the latest to flash one. The New Jersey-based developer of medical devices and specialty chemistries trades far below a dollar, so even a fraction of a cent …
Please wait processing your request...